File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1002/hed.28219
- Scopus: eid_2-s2.0-105008457772
- WOS: WOS:001511959600001
- Find via

Supplementary
- Citations:
- Appears in Collections:
Article: Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma
| Title | Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma |
|---|---|
| Authors | |
| Keywords | chemotherapy immunotherapy nasopharyngeal carcinoma radiation recurrence surgery |
| Issue Date | 20-Jun-2025 |
| Publisher | Wiley |
| Citation | Head Neck, 2025 How to Cite? |
| Abstract | BackgroundRecurrent nasopharyngeal carcinoma (NPC) is associated with challenges in treatment due to the complex anatomic location and impact of prior treatment modalities such as radiation therapy. The purpose of this review is to discuss modern treatment strategies for recurrent NPC, potential challenges, and outcomes. MethodsA narrative review was performed, evaluating management strategies of recurrent NPC, survival measures, and advancements in treatment considerations. ResultsTreatment options including radiation, surgery, and chemotherapy are discussed, including data on survival outcomes and treatment-related morbidity. We review additional considerations including advances in endoscopic surgery, operative management of the internal carotid artery (ICA), novel radiation and chemotherapy protocols, and the introduction of immune checkpoint inhibitors. ConclusionThis review describes contemporary management strategies for recurrent NPC, highlighting evolving management strategies that may reduce treatment-associated morbidity and improve survival. |
| Persistent Identifier | http://hdl.handle.net/10722/357471 |
| ISSN | 2023 Impact Factor: 2.3 2023 SCImago Journal Rankings: 1.034 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pandrangi, Vivek C | - |
| dc.contributor.author | Liao, Jay J | - |
| dc.contributor.author | de Almeida, John R | - |
| dc.contributor.author | El‐Sayed, Ivan H | - |
| dc.contributor.author | Hanna, Glenn | - |
| dc.contributor.author | Su, Shirley Y | - |
| dc.contributor.author | Tsang, Raymond | - |
| dc.contributor.author | Won, Tae‐Bin | - |
| dc.contributor.author | Witterick, Ian | - |
| dc.contributor.author | Choby, Garret | - |
| dc.contributor.author | Kuan, Edward C | - |
| dc.contributor.author | Geltzeiler, Mathew | - |
| dc.date.accessioned | 2025-07-22T03:12:57Z | - |
| dc.date.available | 2025-07-22T03:12:57Z | - |
| dc.date.issued | 2025-06-20 | - |
| dc.identifier.citation | Head Neck, 2025 | - |
| dc.identifier.issn | 1043-3074 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/357471 | - |
| dc.description.abstract | <h3>Background</h3><p>Recurrent nasopharyngeal carcinoma (NPC) is associated with challenges in treatment due to the complex anatomic location and impact of prior treatment modalities such as radiation therapy. The purpose of this review is to discuss modern treatment strategies for recurrent NPC, potential challenges, and outcomes.</p><h3>Methods</h3><p>A narrative review was performed, evaluating management strategies of recurrent NPC, survival measures, and advancements in treatment considerations.</p><h3>Results</h3><p>Treatment options including radiation, surgery, and chemotherapy are discussed, including data on survival outcomes and treatment-related morbidity. We review additional considerations including advances in endoscopic surgery, operative management of the internal carotid artery (ICA), novel radiation and chemotherapy protocols, and the introduction of immune checkpoint inhibitors.</p><h3>Conclusion</h3><p>This review describes contemporary management strategies for recurrent NPC, highlighting evolving management strategies that may reduce treatment-associated morbidity and improve survival.</p> | - |
| dc.language | eng | - |
| dc.publisher | Wiley | - |
| dc.relation.ispartof | Head Neck | - |
| dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
| dc.subject | chemotherapy | - |
| dc.subject | immunotherapy | - |
| dc.subject | nasopharyngeal carcinoma | - |
| dc.subject | radiation | - |
| dc.subject | recurrence | - |
| dc.subject | surgery | - |
| dc.title | Current Trends in the Management of Recurrent Nasopharyngeal Carcinoma | - |
| dc.type | Article | - |
| dc.identifier.doi | 10.1002/hed.28219 | - |
| dc.identifier.scopus | eid_2-s2.0-105008457772 | - |
| dc.identifier.eissn | 1097-0347 | - |
| dc.identifier.isi | WOS:001511959600001 | - |
| dc.identifier.issnl | 1043-3074 | - |
